Jan 2022 $5 M No. 8 $2 to $10 million 6
Advaxis, Inc.: Raise no. 8, Jan 2022 × Investors in this round 6 investors had bought by the notice of Feb 11, 2022: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $380,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees $295,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andres Gutierrez · Executive Officer Igor Gitelman · Executive Officer Kenneth Berlin · Executive Officer, Director David Sidransky · Director James Patton · Director Richard Berman · Director Roni Appel · Director Samir Khleif · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round A.G.P./Alliance Global Partners (CRD 8361) · New York, New York Sold in IL, NY Remarks in the notice On fees: “In connection with the transaction, A.G.P./Alliance Global Partners received placement agent fees in the aggregate amount of $295,000.”On the amounts: “This amount reflects a private placement of 1,000,000 shares of the Company's Series D Convertible Redeemable Preferred Stock, par value $0.001, which will be convertible, at a conversion price of $0.25 per share (subject to adjustments).”On the use of proceeds: “The proceeds from the offering will not be used for payments to any of the persons identified as related persons in response to Item 3.”Signed by Kenneth A. Berlin, President, Chief Executive Officer and Interim CFO. Source: SEC Form D, newest notice filed Feb 11, 2022. Read the notice at the SEC .
equity SEC Apr 2021 $11 M No. 7 $10 to $50 million 2
Advaxis, Inc.: Raise no. 7, Apr 2021 × Investors in this round 2 investors had bought by the notice of Apr 28, 2021: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $11 M offered
Smallest investment taken $3,000,000
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees $1,104,501
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andres Gutierrez · Executive Officer Kenneth Berlin · Executive Officer, Director David Sidransky · Director Igor Gitelman · Director James Patton · Director Richard Berman · Director Roni Appel · Director Samir Khleif · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round A.G.P./Alliance Global Partners (CRD 8361) · New York, New York Sold in IL, NY Remarks in the notice On fees: “In connection with the transaction, A.G.P./Alliance Global Partners received placement agent fees in the aggregate amount of $1,104,501.34, which reflects aggregate fees for private placement and concurrent registered offering.”On the amounts: “Amount reflects purchase price of securities sold in concurrent registered offering which were bundled with private placement warrants to purchase up to 14,005,202 shares of the Company's common stock.”On the use of proceeds: “The proceeds from the offering will not be used for payments to any of the persons identified as related persons in response to Item 3.”Signed by Kenneth A. Berlin, President, Chief Executive Officer and Interim CFO. Source: SEC Form D, newest notice filed Apr 28, 2021. Read the notice at the SEC .
options SEC May 2012 $4 M No. 6 $2 to $10 million 29
Advaxis, Inc.: Raise no. 6, May 2012 × Investors in this round 29 investors had bought by the notice of May 29, 2012: 29 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John L. Rothman · Executive Officer Mark J. Rosenblum · Executive Officer Thomas Moore · Executive Officer, Director James Patton · Director Richard L. Berman · Director Roni A. Appel · Director Thomas L. McKearn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Advaxis did not receive any cash proceeds in the exchanges. However, certain holders of $4,473,673 of Advaxis' convertible promissory notes surrendered such notes and related warrants in exchange for shares and new warrants.”Signed by Mark J. Rosenblum, Chief Financial Officer, Senior Vice President and Secretary. Source: SEC Form D, newest notice filed May 29, 2012. Read the notice at the SEC .
equity, options SEC Jan 2012 $1 M No. 5 Under $2 million 12
Advaxis, Inc.: Raise no. 5, Jan 2012 × Investors in this round 12 investors had bought by the notice of Feb 24, 2012: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock issuable upon conversion of notes.
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $73,325
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John A. Rothman · Executive Officer Mark J. Rosenblum · Executive Officer Thomas Moore · Executive Officer, Director James Patton · Director Richard A. Berman · Director Roni A. Appel · Director Thomas A. McKearn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Rodman & Renshaw, LLC (CRD 16415) · New York, New York Sold in CA, CT, GA, IL, NC, NJ, NY, PA Remarks in the notice On fees: “Rodman & Renshaw, LLC also received warrants to purchase an aggregate of 575,098 shares of Advaxis, Inc.'s common stock as part of its sales commission.”On the amounts: “Advaxis, Inc. received an aggregate purchase price of $1,047,500.00 in return for issuing to the investors (i) an aggregate of $1,232,352.94 of its convertible promissory notes and (ii) warrants to purchase up to 4,107,842 shares of its common stock.”On the use of proceeds: “No amount of the gross proceeds is anticipated to pay named executive officers, except that the issuer may use up to $200,000 of the gross proceeds or other available funds for payments to its CEO for prior outstanding amounts owed to him.”Signed by Mark J. Rosenblum, Chief Financial Officer, Senior Vice President and Secretary. Source: SEC Form D, newest notice filed Feb 24, 2012. Read the notice at the SEC .
debt, options SEC Oct 2011 $2 M No. 4 Under $2 million 12
Advaxis, Inc.: Raise no. 4, Oct 2011 × Investors in this round 12 investors had bought by the notice of Nov 15, 2011: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock issuable upon conversion of notes.
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $110,425
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John A. Rothman · Executive Officer Mark J. Rosenblum · Executive Officer Thomas Moore · Executive Officer, Director James Patton · Director Richard A. Berman · Director Roni A. Appel · Director Thomas A. McKearn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Rodman & Renshaw, LLC (CRD 16415) · New York, New York Sold in CA, CT, GA, IL, NC, NJ, NY, PA Remarks in the notice On fees: “Rodman & Renshaw, LLC also received warrants to purchase an aggregate of 866,078 shares of Advaxis, Inc.'s common stock as part of its sales commission.”On the amounts: “The investors paid an aggregate purchase price of $1,977,500.00 in return for receiving from Advaxis (i) an aggregate of $2,326,470.59 of Advaxis' convertible promissory notes and (ii) warrants to purchase up to 7,754,899 shares of Advaxis' common stock.”On the use of proceeds: “The notes purchased in this offering by Thomas A. Moore, Advaxis' Chairman and Chief Executive Officer, were paid for in exchange for the cancellation of $400,000.00 of outstanding indebtedness owed by Advaxis to Mr. Moore.”Signed by Mark J. Rosenblum, Chief Financial Officer, Senior Vice President and Secretary. Source: SEC Form D, newest notice filed Nov 15, 2011. Read the notice at the SEC .
debt, options SEC May 2011 $6 M No. 3 $2 to $10 million 24
Advaxis, Inc.: Raise no. 3, May 2011 × Investors in this round 24 investors had bought by the notice of May 27, 2011: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M (amount offered: indefinite)
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock issuable upon conversion of notes.
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $360,975
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John A. Rothman · Executive Officer Mark J. Rosenblum · Executive Officer Thomas Moore · Director, Executive Officer James Patton · Director Richard A. Berman · Director Roni A. Appel · Director Thomas A. McKearn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Rodman & Renshaw, LLC (CRD 16415) · Ny, New York Sold in CA, CO, CT, GA, IL, MA, MN, NC, NJ, NY Remarks in the notice On fees: “Rodman & Renshaw, LLC also received warrants to purchase an aggregate of 1,887,448 shares of Advaxis, Inc.'s common stock as part of its sales commission.”On the amounts: “Advaxis, Inc. received an aggregate purchase price of $6,016,250.00 in return for issuing to the investors (i) an aggregate of $7,077,936.29 of its convertible promissory notes and (ii) warrants to purchase up to 23,593,122 shares of its common stock.”On the use of proceeds: “No amount of the gross proceeds is anticipated to pay named executive officers, except that the issuer may use up to $200,000 of the gross proceeds or other available funds for payments to the chief executive officer for prior outstanding amounts owed to”Signed by Mark J. Rosenblum, Chief Financial Officer, Senior Vice President and Secretary. Source: SEC Form D, newest notice filed May 27, 2011. Read the notice at the SEC .
debt, options SEC Jul 2010 $8 M No. 2 $2 to $10 million 1
Advaxis, Inc.: Raise no. 2, Jul 2010 × Investors in this round 1 investor had bought by the notice of Jul 30, 2010: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John A. Rothman · Executive Officer Mark J. Rosenblum · Executive Officer Thomas Moore · Director, Executive Officer James Patton · Director Richard A. Berman · Director Roni A. Appel · Director Thomas A. Mckearn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark J. Rosenblum, Chief Financial Officer, Senior Vice President and Secretary. Source: SEC Form D, newest notice filed Jul 30, 2010. Read the notice at the SEC .
equity, options SEC Sep 2009 $5 M No. 1 $2 to $10 million 1
Advaxis, Inc.: Raise no. 1, Sep 2009 × Investors in this round 1 investor had bought by the notice of Oct 5, 2009: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Fredrick A. Cobb · Executive Officer John M. Rothman · Executive Officer Thomas A. Moore · Executive Officer, Director James M. Patton · Director Richard M. Berman · Director Roni M. Appel · Director Thomas M. McKearn · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas A. Moore, Chief Executive Officer and Chairman. Source: SEC Form D, newest notice filed Oct 5, 2009. Read the notice at the SEC .
options SEC